News Daily News Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies Michael O'Riordan September 27, 2016
News Industry News Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial September 18, 2015
News Industry News US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack September 03, 2015
News Daily News ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves Yael L. Maxwell July 15, 2015
News Daily News ADVANCE Publicado: el Índice de ACV Disminuye a Medida que Evoluciona la TAVR Yael L. Maxwell July 15, 2015
Presentation Incidence and Predictors of Early and Midterm Clinically Relevant Neurological Events After TAVR Presenter: Johan Bosmans July 14, 2015
News Daily News CLOSURE I Analysis Suggests Many Recurrent Strokes Are Unrelated to PFO August 20, 2014